Today, the Honourable Carolyn Bennett, Minister of Mental Health and Addictions and Associate Minister of Health, announced regulatory changes that will come into effect on August 30, 2023, to schedule a group of chemicals, known as novel fentanyl precursors, as precursors under the Controlled Drugs and Substances Act (CDSA).

“Every day, we lose more loved ones to the overdose crisis and the increasingly toxic illegal drug supply. We have to follow all four of the internationally recognized drug policy pillars, including prevention, harm reduction, treatment and law enforcement so that we can continue working together to address this crisis. By helping to disrupt the illegal production of fentanyl and fentanyl analogues, by enabling enforcement to take action against illegal importation, distribution, and use of these illegal substances, we will help to protect the health and safety of Canadians – and save lives.”

The Honourable Carolyn Bennett
Minister of Mental Health and Addictions and Associate Minister of Health

“The safety and security of Canadians is our government’s top priority. Our work begins at the border, where we stop illegal drugs like fentanyl precursors from coming into Canada. I want to thank CBSA employees and law enforcement partners for their commitment and hard work to keep our communities safe.”

The Honourable Marco Mendicino
Minister of Public Safety

• This group of novel fentanyl precursors, which are analogues and derivatives of N-phenyl-4-piperidinamine and its salts, also known as 4-AP, do not have any legitimate industrial, commercial, or medical uses, and controlling them will help to address their use in the illegal production of fentanyl and fentanyl analogues. 

• Since 2017, the Government of Canada has taken evidence-based action to address the overdose crisis and announced over $1 billion to increase access to evidence-based treatment and harm reduction services, fund awareness, prevention, and stigma reduction activities, support research and surveillance initiatives, and strengthen law enforcement capacity to address illegal drug production and trafficking.

• Data on Opioid- and Stimulant-related Harms in Canada show that while the average number of opioid-related deaths per day was eight in 2016, this number has now more than doubled, reaching an all-time high of 21 deaths per day in 2021. The number of opioid-related hospitalizations also grew from 13 per day in 2016, to 17 per day in 2021.

• The Government of Canada works with domestic and international partners to address the toxic illegal drug supply, including by:

  • Providing border services officers with tools and equipment to safely and effectively detect, identify and interdict fentanyl and other toxic substances at the border. As part of Budget 2018 funding for the opioid crisis, the Government of Canada dedicated $31.6 million over five years to equip the Canada Border Services Agency (CBSA) to more safely and effectively detect, identify and interdict fentanyl and other highly toxic substances at ports of entry. The Agency plays a direct role in protecting Canadian communities, by preventing the illegal movement of controlled substances and precursor chemicals across our borders.  

• The CBSA stays current on global trends and patterns to ensure that its front-line border services officers and intelligence personnel are knowledgeable about new and unique concealment methods.

• The CBSA has:

  • Seized over 20 kg of fentanyl at the border between April 2018 and April 2022
  • Seized over 22,000 kg of other narcotics, drugs and chemicals between April 2021 and March 2022.
  • Implemented 81 safe examination areas at high-risk ports of entry to help identify and examine shipments suspected to contain opioids.
  • Maintained field drug analysis sites with on-site chemists in Toronto, Montreal and Vancouver.
  • Added fentanyl detection to the scent profile of six drug and firearm detector dog teams strategically located across the country.
  • Working with private sector partners to address money laundering of the proceeds of fentanyl trafficking.

Associated links

• Government of Canada takes action at the border to help address toxic illegal drug supply in Canada
• Joint Statement on the North American Drug Dialogue Public Health Summit
• Canada-United States Statement on Joint Action Plan on Opioids
• Regulating Controlled Substances and Precursors
• Federal actions on opioids to date
• Trilateral Fentanyl Committee Joint Statement
• Cross Border Crime Forum Joint Statement
• About Fentanyl
• Canada Border Services Agency seizures
• Order Amending Schedule VI to the Controlled Drugs and Substances Act (Novel Fentanyl Precursors)

Maja Staka
Senior Communications Advisor and Press Secretary
Office of the Honourable Carolyn Bennett
Minister of Mental Health and Addictions and Associate Minister of Health
343-552-5568

Media Relations
Public Health Agency of Canada
613-957-2983
media@hc-sc.gc.ca

Public Inquiries
613-957-2991
1-866-225-0709